BioNTech SE (BNTX) Divestments (2019 - 2025)
BioNTech SE (BNTX) posted Divestments of -$1.1 billion for Q3 2025, down 1383.89% sequentially from -$72.9 million in Q2 2025, and down 593.16% YoY from $219.3 million in Q3 2024.
BioNTech SE (BNTX) Divestments (2019 - 2025) Analysis & Trends
BioNTech SE has reported Divestments for 7 years, with the latest figure at -$1.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | -13.21 Mn |
| 10 | Roivant Sciences | 26.39 Bn | 26.39 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.08 Bn |
| Jun 30, 2025 | -72.90 Mn |
| Mar 31, 2025 | 1.31 Bn |
| Sep 30, 2024 | -156.06 Mn |
| Jun 30, 2024 | -259.96 Mn |
| Mar 31, 2024 | -2.50 Bn |
| Sep 30, 2023 | -1.34 Bn |
| Jun 30, 2023 | -2.50 Bn |
| Mar 31, 2023 | -789.34 Mn |
| Sep 30, 2022 | -83.99 Mn |
| Jun 30, 2022 | -83.66 Mn |
| Mar 31, 2022 | 322.56 Mn |
| Sep 30, 2021 | -481.27 Mn |
| Jun 30, 2021 | -35.89 Mn |
| Mar 31, 2021 | 415.07 Mn |
| Sep 30, 2020 | -23.73 Mn |
| Jun 30, 2020 | -10.79 Mn |
| Mar 31, 2020 | -16.49 Mn |
| Sep 30, 2019 | -215.40 Mn |
| Jun 30, 2019 | 70.91 Mn |